학술논문

Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long‐Term Results of Two Phase III Randomized Controlled Trials.
Document Type
Article
Source
Arthritis Care & Research; May2022, Vol. 74 Issue 5, p759-767, 9p
Subject
ANKYLOSING spondylitis
CANCER fatigue
C-reactive protein
SPONDYLOARTHROPATHIES
CHRONIC diseases
FUNCTIONAL assessment
Language
ISSN
2151464X
Abstract
Copyright of Arthritis Care & Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)